Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. To learn more, please visit www.pfizer.com.

Journalist Login



Campaigns

<i>Back in Play</i>

Back in Play

Back in Play is a pan-European campaign supported by Pfizer, ankylosing spondylitis patient groups and professional footballers across Europe, to raise mass awareness of ankylosing spondylitis (AS), a chronic inflammatory condition, affecting the spine, causing severe, chronic pain and discomfort.

» Read more ...

<i>My Day for RA</i>

My Day for RA

My Day for RA is a pan-European educational programme that encourages men and women with rheumatoid arthritis to dedicate a day to learn more about their condition and to set goals in order to feel more confident and empowered to manage their RA now and in the future.

» Read more ...

Welcome to Wyeth's web portal for journalists

Welcome to Wyeth's web portal for journalists. Our aim is to provide journalists with information and updates on the latest Wyeth news with supporting materials to help keep up-to-date with comprehensive information about Wyeth and our therapy areas.

If you are not already registered and interested in material with a medical content please register to access the full resources. 

 

Events

PSORIASIS 2010 - Pfizer symposium

PSORIASIS 2010 - Pfizer symposium

Leading experts will be discussing the different elements of the management of psoriatic arthritis – from detection and early diagnosis, to shared care and practical treatment options.

» Read more ...

Evolution in Inflammation Media Briefing

Evolution in Inflammation Media Briefing

The ‘Evolution in Inflammation’ Media Briefing will be held to coincide with the European League Against Rheumatism (EULAR) Annual Congress taking place from 16-19 June 2010 in Rome, Italy. The first Pfizer inflammatory franchise Media Briefing will take place to highlight the growing body of clinical evidence acquired from the current and the emerging inflammatory treatment portfolio.

» Read more ...

Stay updated

This website will continue to be updated in the run-up to the event, please register for website access to stay updated.

About Wyeth

Wyeth is one of the world's leading pharmaceutical and healthcare products companies. We are research-driven, with a major focus on developing innovative new medicines that really make a difference to people's lives and address significant areas of unmet medical need.  This portal aims to give journalists up to date access to information on our activities and developments.

News Feeds

Wyeth EU RSS News FeedsRegistered users can subscribe to our RSS Feeds to be kept updated with:

  • - Press Releases
  • - Events
  • - Campaigns

» Find out more...

 

Backgrounders

Registered users can access a host of resources including:

  • - Disease definitions
  • - Causes
  • - Co-morbidities
  • - Prevalence